The change of the immunological functions of cancer patients with the administration of interleukin-2
スポンサーリンク
概要
- 論文の詳細を見る
Interleukin-2 (IL-2) was administrated to three cases of progressive oral cancer, and the immunological activities were observed.<BR>Case 1: A 77 year-old man with recurrent squamous cell carcinoma of the buccal mucosa.2.59×10<SUP>7</SUP>JRU (Japan Reference Unit) of IL-2 was injected into the tissue surrounding the tumor for 24 days. The regression of the tumor was observed, and was considered to the partial response (PR) . However, the tumor made progeress and the patient passed away after 4 years.<BR>Case 2: A 62 year-old woman with progressed squamous cell carcinoma of buccal mucosa. 7.7×10<SUP>6</SUP>JRU of IL-2 was injected intravenously for 11 days. The tumor made progress despite the radiation and chemotherapies, the patient underwent and she passed away after 2 months.<BR>Case 3: A 63 year-old man with squamous cell carcinoma of maxillary sinus. After 3 weeks of partial resection of the maxilla the residual tumor was observed on the pterigoid fossa. 1.5×10<SUP>7</SUP>JRU of IL-2 was administrated intravenously with<SUP>60</SUP>Co radiation. The patient has been living without tumor since 1988.<BR>The number of eosinophilic leucocytes were increased in case 1, and the number of total lymphocytes were increased in cases 1 and 3. Some kinds of phenotypes of lymphocytes were in high level in case 2, however they were not increased after treatment. In cases 1 and 3, CD 57 and CD 16 positive cells were increased after the administration of IL-2, and NK and LAK activities were also increased.
- 一般社団法人 日本口腔腫瘍学会の論文
一般社団法人 日本口腔腫瘍学会 | 論文
- 進行口腔癌に対する逆行性超選択的動注化学療法, 放射線同時併用療法後の救済手術
- TS-1による化学療法と温熱放射線療法が著効した後発頸部リンパ節転移の1例
- 手術シミュレーションに基づく腫瘍分割摘出により顎骨を保存した得た下顎骨骨形成線維腫の1例
- 口腔癌における化学・放射線療法後の再発・二次再建に関する外科療法の検討
- 下顎骨再建 : 血管柄付遊離骨移植と遊離軟部組織移植の比較